Estimation of p53 Antibodies in Malignant Effusions
Keywords:Effusions, p53, antibodies, ELISA.
AbstractObjective: To detect the presence of antibodies against p53 protein in the sera and cytologically positive malignant effusions. Design: Cross- sectional study. Place and Duration of study: Department of Pathology, Postgraduate Medical Institute. Lahore from March 1997 to November 1999. Patients and Methods: Forty cancer patients were selected with different types of malignancies and having cytologically positive effusions. Both sera and respective effusion fluid were collected and stored at -200 C. Anti-p35 ELISA was then carried out by using commercially available ELISA kit. according: to the manufacturer's instructions. A positive p53 antibody level corresponded to the presence of antibodies against mutant p53 protein produced as a result of a mutation of p53 gene in the said cancer. Results: Positivity for anti-p53 antibodies was observed in 27 out of 40 era (67.5%) and in 19 out of 40 effusions (47.5%) of patients with different types of cancers. The comparison revealed significant difference with a p value of < 0.05. Out of these, 18 subjects had positive anti-p53 antibodies in both the sera and in respective effusion fluids, yielding an overall sensitivity of 66.65 and specificity of 92.3%. Conclusion: The present study demonstrates the usefulness of anti-p53 antibody estimation both in the serum and in effusions. As a marker of neoplasia and as an adjunct to conventional diagnostic cytopathological techniques especially in those tumours in which p53 gene mutations occur.
How to Cite
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments email@example.com